Sanofi, Stanford partner to study immunology

By The Science Advisory Board staff writers

May 6, 2021 -- Sanofi has entered into a three-year research collaboration with the Stanford University School of Medicine to advance the understanding of immunology and inflammation.

Sanofi will also provide funding and scientific inputs into projects of mutual interest, spanning multiple therapeutic areas including autoimmune diseases and inflammatory conditions. The two organizations will create a joint steering committee to fund up to three programs a year. Sanofi will host an annual research forum for researchers from both organizations to further exchange ideas, share knowledge and perspectives on relevant scientific matters, and discuss collaborative research projects.

The first projects that the collaboration will explore are:

  • Cytokine crosstalk in type 2 inflammation (effect of Sanofi's investigational molecules on excessive type 2 inflammation)
  • Molecular drivers of effector and suppressor T cells in autoimmunity to better understand the specific antigens that may cause type 1 diabetes
  • Mechanisms of immune-related adverse events with immune checkpoint inhibitor therapy (focus on pneumonitis and inflammatory arthritis) to explore the role of genomics and pathogenic cell identification
Sanofi to provide fill/finish services for Moderna COVID-19 vaccine
Moderna has inked a new agreement with Sanofi in order to scale up U.S. manufacturing capacity for its COVID-19 vaccine.
Sanofi acquires Tidal Therapeutics, expands vaccine manufacturing
Sanofi announced that it has purchased Tidal Therapeutics for $160 million and plans to expand its vaccine manufacturing capability through a site...
Sanofi to build new manufacturing facility in Toronto
Sanofi announced an investment of approximately $737 million U.S. in a new vaccine manufacturing facility at its existing site in Toronto, Canada,...
GVN adds Sanofi Pasteur as partner against viral threats
The Global Virus Network (GVN) has added Sanofi Pasteur, the vaccines business unit of Sanofi, as a member of the GVN Healthcare & Pharma Centers of Excellence...

Copyright © 2021

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter